Medtronic has agreed to pay $22 million to settle approximately 950 lawsuits. These lawsuits were a result of injury caused by using Medtronic’s spinal bone graft product, Infuse Bone Graft. The Infuse Bone Graft is used during lower spine repair surgery to stimulate bone growth. Medtronic promoted unapproved uses that created complications in patients.
In addition to the $22 million, Medtronic is reportedly preparing another settlement of $140 million for an even larger number of anticipated claims. Those who have suffered due to the misuse of this product are finally seeing the end of their case nearing.
To find out more about this lawsuit and its history, read our previous blog here.No Comments